504 related articles for article (PubMed ID: 3489128)
21. Immunoadjuvant activities of synthetic N-acetyl-muramyl-peptides or -amino acids.
Kotani S; Watanabe Y; Kinoshita F; Shimono T; Morisaki I
Biken J; 1975 Jun; 18(2):105-11. PubMed ID: 1180867
[TBL] [Abstract][Full Text] [Related]
22. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: dose-response and local reactions observed with selected compounds.
Tsujimoto M; Kotani S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):517-21. PubMed ID: 3744549
[TBL] [Abstract][Full Text] [Related]
23. Role of thymus for N-acetyl muramyl-L-alanyl-D-isoglutamine-induced polyarthritis and granuloma formation in euthymic and athymic nude rats or in neonatally thymectomized rats.
Kohashi O; Pearson CM; Tamaoki N; Tanaka A; Shimamura K; Ozawa A; Kotani S; Saito M; Hioki K
Infect Immun; 1981 Feb; 31(2):758-66. PubMed ID: 7012019
[TBL] [Abstract][Full Text] [Related]
24. Activation of immune responses by muroctasin.
Akasaki M
Arzneimittelforschung; 1988 Jul; 38(7A):976-7. PubMed ID: 3056427
[TBL] [Abstract][Full Text] [Related]
25. Effect of stearoyl-N-acetylmuramyl-L-alanyl-D-isoglutamine on host resistance to Corynebacterium kutscheri infection in cortisone-treated mice.
Ishihara C; Yamamoto K; Hamada N; Azuma I
Vaccine; 1984 Dec; 2(4):261-4. PubMed ID: 6531965
[TBL] [Abstract][Full Text] [Related]
26. Subacute toxicity of muroctasin in mice and dogs.
Ono Y; Iwasaki T; Sekiguchi M; Onodera T
Arzneimittelforschung; 1988 Jul; 38(7A):1024-7. PubMed ID: 3190795
[TBL] [Abstract][Full Text] [Related]
27. Stimulation of plasma fibronectin production in mice by muroctasin.
Endo N; Okuda T; Osada Y; Zen-Yoji H
Arzneimittelforschung; 1988 Jul; 38(7A):997-8. PubMed ID: 3190806
[TBL] [Abstract][Full Text] [Related]
28. Effect of muramyl dipeptide and its stearoyl derivatives on resistance to Sendai virus infection in mice.
Ishihara C; Hamada N; Yamamoto K; Iida J; Azuma I; Yamamura Y
Vaccine; 1985 Dec; 3(5):370-4. PubMed ID: 2417426
[TBL] [Abstract][Full Text] [Related]
29. Augmentation by priming with interferon-gamma of the binding of a muramyl dipeptide derivative to macrophages resulting in synergistic macrophage activation.
Nagao S; Sato K; Osada Y
Jpn J Cancer Res; 1987 Jan; 78(1):80-6. PubMed ID: 3102442
[TBL] [Abstract][Full Text] [Related]
30. [Synthesis and protective activity of beta-glycosides of N-acetylmuramyl-L-alanyl-D-isoglutamine with alkylalicyclic and arylaliphatic aglycons].
Zemliakov AE; Tsikalova VN; Tsikalov VV; Chirva VIa; Mulik EL; Kaliuzhin OV
Bioorg Khim; 2005; 31(6):637-44. PubMed ID: 16363137
[TBL] [Abstract][Full Text] [Related]
31. Inflammatory cytokine production induced by an analogue of muramyl dipeptide MDP-Lys(L18) in rat macrophage cultures and dog synovial fluid.
Sugawara T; Takada S; Miyamoto M; Nomura M; Kato M
Inflammation; 1996 Feb; 20(1):43-56. PubMed ID: 8926048
[TBL] [Abstract][Full Text] [Related]
32. Immunoadjuvant activities of synthetic 6-O-acyl-N-acetylmuramyl-L-alanyl-D-isoglutamine with special reference to the effect of its administration with liposomes.
Kotani S; Kinoshita F; Morisaki I; Shimono T; Okunaga T; Takada H; Tsujimoto M; Watanabe Y; Kato K; Shiba T; Kusumoto S; Okada S
Biken J; 1977 Dec; 20(3-4):95-103. PubMed ID: 614856
[TBL] [Abstract][Full Text] [Related]
33. Induction of colony-stimulating factor and stimulation of stem cell proliferation by injection of muroctasin.
Yamaguchi F; Akasaki M; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):980-3. PubMed ID: 3263869
[TBL] [Abstract][Full Text] [Related]
34. Production of colony-stimulating factor from macrophages by muroctasin.
Yamaguchi F; Akahane K; Takashi T; Tsukada W
Arzneimittelforschung; 1988 Jul; 38(7A):983-6. PubMed ID: 3263870
[TBL] [Abstract][Full Text] [Related]
35. Role of the thymus in streptococcal cell wall-induced arthritis and hepatic granuloma formation. Comparative studies of pathology and cell wall distribution in athymic and euthymic rats.
Allen JB; Malone DG; Wahl SM; Calandra GB; Wilder RL
J Clin Invest; 1985 Sep; 76(3):1042-56. PubMed ID: 3876354
[TBL] [Abstract][Full Text] [Related]
36. Activation of the human complement cascade by bacterial cell walls, peptidoglycans, water-soluble peptidoglycan components, and synthetic muramylpeptides--studies on active components and structural requirements.
Kawasaki A; Takada H; Kotani S; Inai S; Nagaki K; Matsumoto M; Yokogawa K; Kawata S; Kusumoto S; Shiba T
Microbiol Immunol; 1987; 31(6):551-69. PubMed ID: 3670125
[TBL] [Abstract][Full Text] [Related]
37. Adjuvant activity of 6-O-acyl-muramyldipeptides to enhance primary cellular and humoral immune responses in guinea pigs: adaptability to various vehicles and pyrogenicity.
Tsujimoto M; Kotani S; Kinoshita F; Kanoh S; Shiba T; Kusumoto S
Infect Immun; 1986 Sep; 53(3):511-6. PubMed ID: 3744548
[TBL] [Abstract][Full Text] [Related]
38. Restorative activity of muroctasin on leukopenia associated with anticancer treatment.
Tsubura E; Nomura T; Niitani H; Osamura S; Okawa T; Tanaka M; Ota K; Nishikawa H; Masaoka T; Fukuoka M
Arzneimittelforschung; 1988 Jul; 38(7A):1070-4. PubMed ID: 3190800
[TBL] [Abstract][Full Text] [Related]
39. Immunoadjuvant effects of the synthetic muramyl-dipeptide (MDP) N-acetylmuramyl-L-alanyl-D-isoglutamine.
Heymer B; Finger H; Wirsing CH
Z Immunitatsforsch Immunobiol; 1978 Oct; 155(1):87-92. PubMed ID: 706536
[TBL] [Abstract][Full Text] [Related]
40. Protective effect of MDP-Lys(L18), a synthetic derivative of muramyldipeptide, on murine cytomegalovirus infection.
Eizuru Y; Nakagawa N; Hamasuna R; Minamishima Y
Nat Immun; 1992; 11(4):225-36. PubMed ID: 1384831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
